RecruitingNot ApplicableNCT06254534

Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy

Effect of Lidocaine, Dexmedetomidine, Esmolol and Magnesium Use on Optic Nerve Sheath Diameter and Hemodynamic Response After Laryngoscopy: Randomized, Controlled, Double-blind Trial


Sponsor

Haseki Training and Research Hospital

Enrollment

100 participants

Start Date

Feb 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial aims to compare the effects of lidocaine, dexmedetomidine, esmolol, and magnesium on optic nerve sheath diameter and hemodynamic response to laryngoscopy. The participants will be patients determined to need intubation and general anesthesia for any elective surgery. Each participant will receive either lidocaine, dexmedetomidine, esmolol, magnesium, or none before anesthesia induction, according to randomization. The investigator will measure the optic nerve sheath diameter by ultrasonography before and after intubation. Researchers will compare the difference between optic nerve sheath diameter, systolic blood pressure, and heart rate before and after laryngoscopy and search for the most stable group. The trial aims to determine a general anesthesia induction protocol for patients sensitive to intracranial pressure changes reflected as optic nerve sheath diameter for easy monitoring.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study compares four different medications — lidocaine, dexmedetomidine, esmolol, and magnesium — used to reduce the body's stress response during the insertion of a breathing tube (endotracheal intubation) for general anesthesia. The goal is to find which drug best prevents the dangerous spike in heart rate and blood pressure that can occur during this procedure. **You may be eligible if...** - You are aged 18–80 and scheduled for a surgical procedure requiring general anesthesia with a breathing tube - You have an ASA physical status of I, II, or III (generally healthy to mild-moderately ill) **You may NOT be eligible if...** - You are allergic to dexmedetomidine, esmolol, lidocaine, or magnesium - You have uncontrolled high blood pressure or severe heart failure - You have a heart rhythm disorder (arrhythmia) - You have severe kidney or liver disease - You have a known brain or neurological condition, or a history of seizures - Your airway was difficult to manage during intubation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESToptic nerve ultrasonography

The primary investigator measured ONSD at times: first after anesthesia induction before laryngoscopy, second just after laryngoscopy, third five minutes after, and fourth ten minutes after intubation by ultrasound guidance with a high-frequency linear probe at T2 ophthalmic preset.


Locations(1)

Haseki Trainig and Research Hospital

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06254534


Related Trials